Senate Finance Committe Chair Ron Wyden (Graeme Sloan/Sipa via AP Images)
What's going on with Merck's offshore tax practices as tax rate plunges to 11% and Senate Finance Chair Ron Wyden digs in
Senate Finance Committee Chair Ron Wyden (D-OR) is looking into the way pharma companies are using subsidiaries in low- or zero-tax countries to lower their …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.